The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Cytiva, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, LabVantage.
Biologics Manufacturing
Cytiva in $31-M US Gov’t Pact for Consumables for COVID Vaccines...
The latest from CDMOs, CMOs, and suppliers featuring Cambrex, Recipharm, NextPharma, SPI Pharma, Sharp Services, and Evotec.
Chemicals/Chemical API Manufacturing
Cambrex Completes Expansion of Solid-Form Screening Facility Cambrex has completed...
Thermo Fisher Scientific has announced plans to invest $130 million for a new sterile manufacturing facility in Singapore.
The new facility will initially include a high-speed sterile line approved for live virus filling and an additional line for...
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has invested $60 million in a new facility in San Diego, California for late-phase and commercial manufacturing.
The new facility is approximately 50,000 square feet and...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Rentschler Biopharma, Fujifilm, Cobra Biologics, Recipharm, and Kindred Biosciences.
Biologics Manufacturing
Rentschler Biopharma, BioNTech in COVID-19 Mfg Vaccine...
The latest from CDMOs, CMOs, and suppliers featuring Lonza, Fujifilm Diosynth Biotechnologies, Stevanato Group, Oxford Biomedica, Catalent, Evonik, and CellGenix.
Biologics Manufacturing
Lonza Launches Pyrogen Testing SystemLonza Bioscience has...
Siegfried, a CDMO of active pharmaceutical ingredients and drug products, has signed binding agreements with Novartis to acquire two Novartis’ drug-product manufacturing sites in Spain.
One site, in El Masnou, specializes in the manufacturing of...
Sartorius, a provider of products and services for the life sciences, has agreed to acquire BIA Separations, an Ajdovščina, Slovenia-headquartered developer and manufacturer of purification products, for EUR 360 million ($423 million).
BIA...
Sterling Pharma Solutions, a Dudley, UK-based CDMO of small-molecule active pharmaceutical ingredients (APIs) and intermediates, has acquired a small-molecule API manufacturing facility in Germantown, Wisconsin from Alcami, a CDMO of APIs and drug...
The latest from CDMOs, CMOs, and suppliers featuring Stevanato Group, PCI Pharma Services, Almac, Hitachi Chemical, BioDuro, and Sundia.
Biologics Manufacturing
Hitachi Chemical Renames Regenerative Medicine CDMO Business The regenerative...
Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, has entered into an agreement with Janssen Pharmaceuticals, one of the Janssen Pharmaceutical Companies of Johnson & Johnson...
Arranta Bio, a CDMO focused on live therapeutic products and the human microbiome, has reported the mechanical completion of GMP suites at its new $100-million manufacturing facility in Watertown, Massachusetts.
Arranta is investing more than $100...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Thermo Fisher Scientific and Hovione.
Biologics Manufacturing
Thermo Fisher, Humanigen in Mfg Pact for COVID-19 mAb CandidateThermo Fisher Scientific and Humanigen, a...
The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma Solutions, Catalent, Metrics Contract Services, Aphena, Vetter, and BioLife.
Biologics Manufacturing
BioLife Solutions To Acquire SciSafe for $30 MBioLife Solutions, a Bothell,...
AstraZeneca and Samsung Biologics, an Incheon, South Korea-based contract biologics manufacturer, have entered into a long-term supply agreement, valued at approximately $330.8 million, to support AstraZeneca’s biologics therapeutics.
Under the...
